Shanghai Haoyuan Chemexpress Co.Ltd(688131) : it is proposed to acquire 100% equity of drug source drugs, and the trading of shares is suspended

On February 18, Shanghai Haoyuan Chemexpress Co.Ltd(688131) announced that the company plans to acquire 100% equity of pharmaceutical drugs held by Wang Yuan, Shanghai Yuanmeng enterprise management consulting partnership (limited partnership), Qidong Yuanli enterprise management consulting partnership (limited partnership) and Ningbo Jiusheng innovative pharmaceutical technology Co., Ltd. by issuing shares and paying cash, At the same time, it is proposed to issue shares to the controlling shareholder of the company, Shanghai Anshu Information Technology Co., Ltd., to raise supporting funds of no more than 50 million yuan. The trading of the company’s shares has been suspended since February 21, and the suspension is expected to be no more than 10 trading days.